50 Hampshire Street
2 articles with EQRX
EQRx Scales Disruptive Model of Important New Medicines at Lower Prices with $500M Series B Financing
Syndicate includes all Series A investors, preeminent life science and generalist funds, and market-leading health systems and payers
BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life sciences companies in North America that recently launched.